Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$12.26 - $23.78 $532,427 - $1.03 Million
-43,428 Reduced 63.6%
24,853 $328,000
Q1 2024

May 15, 2024

SELL
$21.9 - $28.28 $120,471 - $155,568
-5,501 Reduced 7.46%
68,281 $1.61 Million
Q4 2023

Feb 14, 2024

BUY
$19.54 - $28.66 $589,541 - $864,700
30,171 Added 69.18%
73,782 $2.02 Million
Q2 2023

Aug 14, 2023

BUY
$11.16 - $23.65 $486,698 - $1.03 Million
43,611 New
43,611 $983,000
Q3 2022

Nov 14, 2022

BUY
$7.46 - $19.28 $42,954 - $111,014
5,758 Added 47.33%
17,923 $198,000
Q2 2022

Aug 15, 2022

BUY
$15.06 - $30.65 $183,204 - $372,857
12,165 New
12,165 $197,000
Q3 2021

Nov 15, 2021

SELL
$45.91 - $59.67 $582,138 - $756,615
-12,680 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$43.3 - $67.17 $351,163 - $544,748
8,110 Added 177.46%
12,680 $744,000
Q1 2021

May 17, 2021

SELL
$44.11 - $90.64 $203,832 - $418,847
-4,621 Reduced 50.28%
4,570 $267,000
Q4 2020

Feb 16, 2021

BUY
$33.89 - $49.88 $311,482 - $458,447
9,191 New
9,191 $427,000
Q2 2020

Aug 14, 2020

SELL
$19.21 - $28.53 $579,853 - $861,178
-30,185 Closed
0 $0
Q1 2020

May 15, 2020

SELL
$11.17 - $28.72 $247,538 - $636,463
-22,161 Reduced 42.34%
30,185 $554,000
Q4 2019

Feb 14, 2020

SELL
$19.29 - $25.52 $21,354 - $28,250
-1,107 Reduced 2.07%
52,346 $1.24 Million
Q3 2019

Nov 14, 2019

BUY
$21.72 - $35.38 $433,292 - $705,795
19,949 Added 59.54%
53,453 $1.17 Million
Q2 2019

Aug 14, 2019

BUY
$20.59 - $35.2 $251,589 - $430,108
12,219 Added 57.41%
33,504 $1.13 Million
Q1 2019

May 15, 2019

SELL
$17.28 - $25.83 $16,260 - $24,306
-941 Reduced 4.23%
21,285 $550,000
Q4 2018

Feb 14, 2019

BUY
$16.17 - $20.8 $359,394 - $462,300
22,226 New
22,226 $407,000

Others Institutions Holding QTRX

About Quanterix Corp


  • Ticker QTRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 36,987,600
  • Market Cap $426M
  • Description
  • Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. It offers HD-X instrument, a sensitive automated multiplex protein detecti...
More about QTRX
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.